ScoreComparison
Why is Intra-Cellular Therapies, Inc. ?
1
The company has declared Positive results for the last 12 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD -73.18 MM
- NET PROFIT(HY) Higher at USD -43.21 MM
- ROCE(HY) Highest at -8.58%
2
Risky - Not traded in last 10 days
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 0%, its profits have risen by 46.5%
3
High Institutional Holdings at 99.61%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Intra-Cellular Therapies, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals: Major should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals: Major)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Intra-Cellular Therapies, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Intra-Cellular Therapies, Inc.
95.89%
1.93
49.73%
S&P 500
13.22%
0.61
20.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
268.75%
EBIT Growth (5y)
4.43%
EBIT to Interest (avg)
-211.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.87
Sales to Capital Employed (avg)
0.57
Tax Ratio
0.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
99.61%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
12.21
EV to EBIT
-111.57
EV to EBITDA
-112.06
EV to Capital Employed
86.89
EV to Sales
19.13
PEG Ratio
NA
Dividend Yield
0.01%
ROCE (Latest)
-77.88%
ROE (Latest)
-6.50%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Intra-Cellular Therapies, Inc.
Operating Cash Flow
Highest at USD -73.18 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 199.22 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -43.21 MM
than preceding 12 month period ended Dec 2024MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
At USD 199.22 MM has Grown at 50.81%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 2,011.13 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 3%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
